New antibody IMT-009 enters human trials for Hard-to-Treat cancers
NCT ID NCT05565417
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 24 times
Summary
This early-phase trial tests a new drug called IMT-009 in about 67 people with advanced solid tumors or lymphomas that have not responded to standard treatments. The main goals are to find a safe dose, understand side effects, and see if the drug can shrink tumors. The study is open-label, meaning everyone knows they are getting the experimental drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 3000
Nashville, Tennessee, 37203, United States
-
Site 4060
Sarasota, Florida, 34232, United States
-
Site 4100
Orlando, Florida, 32827, United States
-
Site 4500
Oklahoma City, Oklahoma, 73104, United States
-
Site 5000
Denver, Colorado, 80218, United States
-
Site 9112
Fairfax, Virginia, 22031, United States
-
Site 9280
Portland, Oregon, 97239, United States
-
Site 9384
Austin, Texas, 78705, United States
-
Site 9618
Tucson, Arizona, 85711, United States
Conditions
Explore the condition pages connected to this study.